Search results for: 'Companies-To-Action'
- Did you mean
- companies to activ
- companies to active
-
20 Nov 2017  |  North America  |  Market Research
Global Biologics Market—Companies-to-Action
Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development
This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...
$3,000.00
Special Price $2,250.00 save 25 %
-
11 Mar 2019  |  North America  |  Market Research
Global Cell Therapy Market—Companies to Action, 2018
A Collaborative Business Model With Focus on Stem Cells, Chimeric Antigen Receptor T (CAR-T) Cells and Combination Therapies Will Propel Market Growth
The global pharmaceutical industry is continuously evolving. with the rising need for novel therapies in the ever-changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as continuously growing number of cancer cases, market needs are shifting from traditional, small molecules to novel, large-molecule the...
$3,000.00
Special Price $2,250.00 save 25 %
-
11 Apr 2019  |  North America  |  Market Research
Pharma Clinical Trial Digitization—Companies to Action, 2019
Collision of Healthcare with Life Sciences IT Systems will Continue to Transform the Clinical Trials Market
Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-centri...
$1,500.00
Special Price $1,125.00 save 25 %
-
11 Apr 2019  |  North America  |  Market Research
Global Cardiovascular Digital Solutions Market—Companies to Action, 2019
Innovative Leaders are Transforming the Cardiovascular Patient Journey
Over the last few decades, modernization-driven lifestyle changes have had major implications on people’s health and well-being. Today, chronic health condition such as cardiovascular diseases (CVD) claim more lives than all forms of cancer combined, accounting for 31% of all deaths worldwide. In the United States alone, 800,000 people succumbed to...
$1,500.00
Special Price $1,125.00 save 25 %
-
04 Sep 2018  |  North America  |  Market Research
Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018
Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities
The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally en...
$3,000.00
Special Price $2,250.00 save 25 %
-
14 Mar 2017  |  North America  |  Market Research
Game-changing Strategies of Leading US Pharma Companies
Focus on Beyond the Pill Services, Process Automation, and Patient Engagement across the Value Chain to Drive Growth
The research service primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights into the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalization of key processes ac...
$1,500.00
Special Price $1,125.00 save 25 %
-
28 Apr 2006  |  North America  |  Market Research
Analysis of Top 10 Specialty Pharmaceutical Companies
This research service provides a detailed overview and analysis of ten specialty pharmaceutical companies. They have been chosen by taking into account certain critical indicators such as revenues, research and development (R&D) expenditure, current drug pipeline, earnings per share, stock price appreciation, return on investment, and net income.
$4,950.00
Special Price $3,712.50 save 25 %
-
09 Nov 2021  |  North America  |  Market Research
US Value-based Care: Trends & Business Implications for Medical Device Companies
Growth Strategies Alignment Assessment
Value-based care (VBC) model aims at providing better outcome and care quality to patients in a cost-effective manner. The revenue risk and incentive for providing better value could be shared between multiple stakeholders including payers, healthcare providers, medical technology participants, and others. The study focuses on providing a detailed ...
$2,450.00
Special Price $1,837.50 save 25 %
-
11 Oct 2023  |  North America  |  Frost Radar
Frost Radar™: Healthcare IoT Security in the United States, 2023
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
In a highly competitive market with increasing regulatory pressures, Frost & Sullivan has analyzed the current state of the Internet of Medical Things (IoMT) security industry and presents the results of its research in this Frost Radar™, a benchmarking system to spark companies to action according to parameters of growth and innovation. The repo...
$4,950.00
Special Price $3,712.50 save 25 %
-
22 Sep 2023  |  North America  |  Frost Radar
Frost Radar™: Clinical Decision Support Systems in North America, 2023
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ investigates the growth and innovation activity of clinical decision support system (CDSS) providers in their pursuit to help end users take the next best medical care action. A CDSS provides professionals with access to organized clinical knowledge integrated with the patient’s medical profile to improve their health and overall ...
$4,950.00
Special Price $3,712.50 save 25 %